Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome, September 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 66 articles:
HTML format


 

Single Articles

  1. KAMAL A, Padival R, Lashner B
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086585. doi: 10.1093.
    Abstract    



  2. RIEHL ME
    The Emerging Role of Brain-Gut Therapies for Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2018;14:436-438.
    Abstract    



  3. LICHTENSTEIN GR
    Brain-Gut Therapies and Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2018;14:399.
    Abstract    



  4. STRUYF N, Vandewiele H, Herrera-Malaver B, Verspreet J, et al
    Kluyveromyces marxianus yeast enables the production of low FODMAP whole wheat breads.
    Food Microbiol. 2018;76:135-145.
    Abstract    

    Abstract available

  5. SOCHAL M, Mosinska P, Fichna J
    Diagnostic value of chemerin in lower gastrointestinal diseases-A review.
    Peptides. 2018 Aug 27. pii: S0196-9781(18)30154.
    Abstract    

    Abstract available

  6. HARDING K, Simpson T, Kearney DJ
    Reduced Symptoms of Post-traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans.
    J Altern Complement Med. 2018 Aug 30. doi: 10.1089/acm.2018.0135.
    Abstract    

    Abstract available

  7. HAMID K, Dayalani N, Jabbar M, Saah E, et al
    My tummy hurts - a case report of abdominal pain and macrocytic anemia caused by hypothyroidism.
    Endocrinol Diabetes Metab Case Rep. 2018;2018.
    Abstract    

    Abstract available

  8. LEE HJ, Cha JY
    Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.
    BMB Rep. 2018 Aug 30. pii: 4323.
    Abstract    

    Abstract available

  9. HATTAY P, Prusator DK, Johnson AC, Greenwood-Van Meerveld B, et al
    Stereotaxic Exposure of the Central Nucleus of the Amygdala to Corticosterone Increases Colonic Permeability and Reduces Nerve-Mediated Active Ion Transport in Rats.
    Front Neurosci. 2018;12:543.
    Abstract    

    Abstract available

  10. CHUAH KH, Mahadeva S
    Cultural factors influencing Functional Gastrointestinal Disorders in the East.
    J Neurogastroenterol Motil. 2018 Aug 29. pii: jnm18064. doi: 10.5056/jnm18064.
    Abstract    

    Abstract available

  11. HONG SW, Chun J, Park S, Lee HJ, et al
    Aloe Vera is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2018 Aug 29. pii: jnm18077. doi: 10.5056/jnm18077.
    Abstract    

    Abstract available

  12. SMITH ZL, Gregory MH, Elsner J, Alajlan BA, et al
    Health-Related quality of life and long-term outcomes after endoscopic therapy for walled-off pancreatic necrosis.
    Dig Endosc. 2018 Aug 27. doi: 10.1111/den.13264.
    Abstract    

    Abstract available

  13. BALIKJI S, Mackus M, Brookhuis KA, Garssen J, et al
    The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome Complaints.
    J Clin Med. 2018;7.
    Abstract    

    Abstract available

  14. KOLACZ J, Porges SW
    Corrigendum: Chronic Diffuse Pain and Functional Gastrointestinal Disorders After Traumatic Stress: Pathophysiology Through a Polyvagal Perspective.
    Front Med (Lausanne). 2018;5:229.
    Abstract    

    Abstract available

  15. CHASE CR
    The Geometry of Emotions: Using Chakra Acupuncture and 5-Phase Theory to Describe Personality Archetypes for Clinical Use.
    Med Acupunct. 2018;30:167-178.
    Abstract    

    Abstract available

  16. NEUBAUER K, Matusiewicz M, Bednarz-Misa I, Gorska S, et al
    Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD.
    Gastroenterol Res Pract. 2018;2018:7265812.
    Abstract    

    Abstract available

  17. GHAVAMI SB, Rostami E, Sephay AA, Shahrokh S, et al
    Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
    Microb Pathog. 2018;117:285-289.
    Abstract    

    Abstract available

  18. AHMED I, Niaz Z, Ewbank F, Akarca D, et al
    Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkers.
    Biomark Med. 2018 Sep 7. doi: 10.2217/bmm-2018-0074.
    Abstract    

    Abstract available

  19. PANNEMANS J, Corsetti M
    Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?
    Curr Opin Pharmacol. 2018;43:53-58.
    Abstract    

    Abstract available

  20. VAN MOH F, Vetter J, Lai HH
    Comparison of urologic and non-urologic presentation in interstitial cystitis/bladder pain syndrome patients with and without Hunner lesions.
    Neurourol Urodyn. 2018 Sep 6. doi: 10.1002/nau.23812.
    Abstract    

    Abstract available

  21. CHAO G, Wang Y, Ye F, Zhang S, et al
    Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang.
    Yonsei Med J. 2018;59:945-950.
    Abstract    

    Abstract available

  22. FREDERICKS E, Dealtry G, Roux S
    beta-Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APC.
    Can J Gastroenterol Hepatol. 2018;2018:4379673.
    Abstract    

    Abstract available

  23. ARASTEH P, Maharlouei N, Eghbali SS, Amini M, et al
    A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort Study.
    Middle East J Dig Dis. 2018;10:149-159.
    Abstract    

    Abstract available

  24. KOSAKO M, Akiho H, Miwa H, Kanazawa M, et al
    Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey.
    Biopsychosoc Med. 2018;12:12.
    Abstract    

    Abstract available

  25. MENEZES LAA, Minervini F, Filannino P, Sardaro MLS, et al
    Effects of Sourdough on FODMAPs in Bread and Potential Outcomes on Irritable Bowel Syndrome Patients and Healthy Subjects.
    Front Microbiol. 2018;9:1972.
    Abstract    

    Abstract available

  26. HE L, Xie M, Zhang H, Meng L, et al
    Autonomic dysfunction in patients with irritable bowel syndrome evidenced by alterations of salivary alpha-amylase secretion.
    Neuro Endocrinol Lett. 2018;39:125-129.
    Abstract    

    Abstract available

  27. THORNTON CS, Rubin JE, Greninger AL, Peirano G, et al
    Epidemiological and genomic characterization of community-acquired Clostridium difficile infections.
    BMC Infect Dis. 2018;18:443.
    Abstract    

    Abstract available

  28. KEITA AV, Soderholm JD
    Mucosal permeability and mast cells as targets for functional gastrointestinal disorders.
    Curr Opin Pharmacol. 2018;43:66-71.
    Abstract    

    Abstract available

  29. COATES MD, Vrana KE, Ruiz-Velasco V
    The influence of voltage-gated sodium channels on human gastrointestinal nociception.
    Neurogastroenterol Motil. 2018 Sep 14:e13460. doi: 10.1111/nmo.13460.
    Abstract    

    Abstract available

  30. GOLDENBERG JZ, Ward L, Day A, Cooley K, et al
    Naturopathic Approaches to Irritable Bowel Syndrome-A Delphi Study.
    J Altern Complement Med. 2018 Sep 12. doi: 10.1089/acm.2018.0255.
    Abstract    

    Abstract available

  31. CHEDID V, Vijayvargiya P, Camilleri M
    Elobixibat for the Treatment of Constipation.
    Expert Rev Gastroenterol Hepatol. 2018.
    Abstract    

    Abstract available

  32. FENTON BT, Goulet JL, Bair MJ, Cowley T, et al
    Relationships Between Temporomandibular Disorders, MSD Conditions, and Mental Health Comorbidities: Findings from the Veterans Musculoskeletal Disorders Cohort.
    Pain Med. 2018;19.
    Abstract    

    Abstract available

  33. FRABERGER V, Call LM, Domig KJ, D'Amico S, et al
    Applicability of Yeast Fermentation to Reduce Fructans and Other FODMAPs.
    Nutrients. 2018;10.
    Abstract    

    Abstract available

  34. SCRIVEN M, Dinan TG, Cryan JF, Wall M, et al
    Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling.
    Diseases. 2018;6.
    Abstract    

    Abstract available

  35. MUMOLO MG, Bertani L, Ceccarelli L, Laino G, et al
    From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
    World J Gastroenterol. 2018;24:3681-3694.
    Abstract    

    Abstract available

  36. DONG TS, Gupta A
    Influence of Early Life, Diet, and the Environment on the Microbiome.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30946.
    Abstract    

    Abstract available

  37. WRIGHT JH, McCray LW, Eells TD, Gopalraj R, et al
    Computer-Assisted Cognitive-Behavior Therapy in Medical Care Settings.
    Curr Psychiatry Rep. 2018;20:92.
    Abstract    

    Abstract available

  38. KURUVILLA ME, Mathew S, Avadhani V
    Treatment of refractory mastocytic enterocolitis with budesonide.
    J Gastrointestin Liver Dis. 2018;27:327-329.
    Abstract    

    Abstract available

  39. REJ A, Avery A, Ford AC, Holdoway A, et al
    Clinical application of dietary therapies in irritable bowel syndrome.
    J Gastrointestin Liver Dis. 2018;27:307-316.
    Abstract    

    Abstract available

  40. RADU M, Moldovan R, Pintea S, Baban A, et al
    Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    J Gastrointestin Liver Dis. 2018;27:257-263.
    Abstract    

    Abstract available

  41. HOD K, Sperber AD, Maharshak N, Ron Y, et al
    Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
    Neurogastroenterol Motil. 2018 Sep 21:e13464. doi: 10.1111/nmo.13464.
    Abstract    

    Abstract available

  42. HARDMAN DI, Geraghty AW, Lewith G, Lown M, et al
    From substance to process: A meta-ethnographic review of how healthcare professionals and patients understand placebos and their effects in primary care.
    Health (London). 2018 Sep 21:1363459318800169. doi: 10.1177/1363459318800169.
    Abstract    

    Abstract available

  43. DENG DX, Tan J, Zhang H, Huang GL, et al
    [Electroacupuncture Relieves Visceral Hypersensitivity by Down-regulating Mast Cell NumberPAR-2/TRPV 1 Signaling, etc. in Colonic Tissue of Rats with Irritable Bowel Syndrome].
    Zhen Ci Yan Jiu. 2018;43:485-91.
    Abstract    

    Abstract available

  44. ZHOU C, Zhao E, Li Y, Jia Y, et al
    Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials.
    Neurogastroenterol Motil. 2018 Sep 19:e13461. doi: 10.1111/nmo.13461.
    Abstract    

    Abstract available

  45. LU M, Wang Z
    Microbiota and Aging.
    Adv Exp Med Biol. 2018;1086:141-156.
    Abstract    

    Abstract available

  46. FAN W, Fei G, Li X, Wang X, et al
    Sera with anti-enteric neuronal antibodies from patients with irritable bowel syndrome promote apoptosis in myenteric neurons of guinea pigs and human SH-Sy5Y cells.
    Neurogastroenterol Motil. 2018 Sep 17:e13457. doi: 10.1111/nmo.13457.
    Abstract    

    Abstract available

  47. BENNET SMP, Sundin J, Magnusson MK, Strid H, et al
    Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.
    Neurogastroenterol Motil. 2018 Sep 17:e13468. doi: 10.1111/nmo.13468.
    Abstract    

    Abstract available

  48. KANE JS, Irvine AJ, Derwa Y, Ford AC, et al
    Fatigue and its associated factors in microscopic colitis.
    Therap Adv Gastroenterol. 2018;11:1756284818799599.
    Abstract    

    Abstract available

  49. CAVIEZEL D, Maissen S, Niess JH, Kiss C, et al
    High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.
    Inflamm Intest Dis. 2018;2:200-210.
    Abstract    

    Abstract available

  50. CREMON C, Barbaro MR, Ventura M, Barbara G, et al
    Pre- and probiotic overview.
    Curr Opin Pharmacol. 2018;43:87-92.
    Abstract    

    Abstract available

  51. WANG Y, Fan H, Qi X, Lai Y, et al
    Are personalized tongxie formula based on diagnostic analyses more effective in reducing IBS symptoms?-A randomized controlled trial.
    Complement Ther Med. 2018;40:95-105.
    Abstract    

    Abstract available

  52. MEYER R, Werthmann PG, Kienle GS
    Reduction of the frequency of recurrent diverticulitis episodes under treatment with the integrative medicine therapies Carpellum Mali comp. and Kalium aceticum comp.-A case report.
    Complement Ther Med. 2018;40:203-206.
    Abstract    

    Abstract available

  53. SCHMULSON M, Bashashati M
    Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Curr Opin Pharmacol. 2018;43:72-80.
    Abstract    

    Abstract available

  54. ALBUSODA A, Ruffle JK, Friis KA, Gysan MR, et al
    Systematic review and meta-analysis: conditioned pain modulation in patients with the irritable bowel syndrome.
    Aliment Pharmacol Ther. 2018 Sep 11. doi: 10.1111/apt.14965.
    Abstract    

    Abstract available

  55. LACY BE
    Review article: an analysis of safety profiles of the treatments for diarrhoea-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2018 Sep 7. doi: 10.1111/apt.14948.
    Abstract    

    Abstract available

  56. FORD AC, Lacy BE, Harris LA, Quigley EM, et al
    Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0222.
    Abstract    

    Abstract available

  57. RAHMAN MM, Ghoshal UC, Sultana S, Kibria MG, et al
    Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0208.
    Abstract    

    Abstract available

  58. LIN MJ, Yu BP
    Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus.
    Dig Dis Sci. 2018 Aug 29. pii: 10.1007/s10620-018-5261.
    Abstract    

    Abstract available

  59. KILLIAN LA, Chapman-Novakofski KM, Lee SY
    Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable.
    Dig Dis Sci. 2018 Sep 19. pii: 10.1007/s10620-018-5289.
    Abstract    

    Abstract available

  60. HELWIG U, Koch AK, Koppka N, Holtmann S, et al
    The Predictive Value of the Hydrogen Breath Test in the Diagnosis of Fructose Malabsorption.
    Digestion. 2018 Sep 4:1-8. doi: 10.1159/000489877.
    Abstract    

    Abstract available

  61. LEI WY, Chang WC, Wong MW, Hung JS, et al
    Sleep Disturbance and Its Association with Gastrointestinal Symptoms/Diseases and Psychological Comorbidity.
    Digestion. 2018 Sep 4:1-8. doi: 10.1159/000490941.
    Abstract    

    Abstract available

  62. FORD AC
    Intending to Treat Patients with Irritable Bowel Syndrome with Cognitive Behavioral Therapy.
    Gastroenterology. 2018 Sep 18. pii: S0016-5085(18)35027.
    Abstract    



  63. HOLLISTER EB, Cain KC, Shulman RJ, Jarrett ME, et al
    Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2018 Aug 24. doi: 10.1097/MCG.0000000000001107.
    Abstract    

    Abstract available

  64. MOHSENABADI H, Zanjani Z, Shabani MJ, Arj A, et al
    A randomized clinical trial of the Unified Protocol for Transdiagnostic treatment of emotional and gastrointestinal symptoms in patients with irritable bowel syndrome: evaluating efficacy and mechanism of change.
    J Psychosom Res. 2018;113:8-15.
    Abstract    

    Abstract available

  65. HUNT MG, Wong C, Aajmain S, Dawodu I, et al
    Fecal incontinence in people with self-reported irritable bowel syndrome: Prevalence and quality of life.
    J Psychosom Res. 2018;113:45-51.
    Abstract    

    Abstract available

  66. KROGSGAARD LR, Engsbro AL, Bytzer P
    Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort.
    Scand J Gastroenterol. 2018 Sep 6:1-4. doi: 10.1080/00365521.2018.1500638.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;